tiprankstipranks
Advertisement
Advertisement

PLRX Stock Latest News

Pliant Therapeutics receives Fast Track designation from FDA for PLN-101095
The FlyPliant Therapeutics receives Fast Track designation from FDA for PLN-101095
6d ago
PLRX
Pliant Therapeutics reports Q2 EPS (36c), consensus (34c)
PremiumThe Fly
Pliant Therapeutics reports Q2 EPS (36c), consensus (34c)
7d ago
PLRX
PLRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PLRX Earnings this Week: How Will it Perform?
16d ago
PLRX
Pliant Therapeutics adds independent directors to strengthen R&D
PremiumCompany Announcements
Pliant Therapeutics adds independent directors to strengthen R&D
1M ago
8K
PLRX
Pliant Therapeutics Shareholders Approve Directors and Executive Pay
PremiumCompany Announcements
Pliant Therapeutics Shareholders Approve Directors and Executive Pay
2M ago
8K
PLRX
Analyst Reiterates Hold on Pliant Therapeutics, Keeps 12-Month Price Target Unchanged at $3 Amid Early-Stage Risk-Reward Balance
PremiumRatingsAnalyst Reiterates Hold on Pliant Therapeutics, Keeps 12-Month Price Target Unchanged at $3 Amid Early-Stage Risk-Reward Balance
3M ago
PLRX
Pliant Therapeutics reports Q1 EPS (32c), consensus (36c)
Premium
The Fly
Pliant Therapeutics reports Q1 EPS (32c), consensus (36c)
3M ago
PLRX
PLRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PLRX Earnings this Week: How Will it Perform?
4M ago
PLRX
Pliant Therapeutics doses first participant in FORTIFY expansion trial
PremiumThe Fly
Pliant Therapeutics doses first participant in FORTIFY expansion trial
4M ago
PLRX
Pliant announces presentation of updated data from Phase 1 trial of PLN-101095
PremiumThe Fly
Pliant announces presentation of updated data from Phase 1 trial of PLN-101095
4M ago
PLRX
Pliant Therapeutics Announces Board Retirements and Option Repricing
PremiumCompany Announcements
Pliant Therapeutics Announces Board Retirements and Option Repricing
4M ago
8K
PLRX
Pliant Therapeutics Launches New $50 Million ATM Program
PremiumCompany Announcements
Pliant Therapeutics Launches New $50 Million ATM Program
5M ago
8K
PLRX
Pliant Therapeutics files $300M mixed securities shelf
PremiumThe FlyPliant Therapeutics files $300M mixed securities shelf
5M ago
PLRX
Pliant Therapeutics price target lowered to $3 from $4 at Canaccord
Premium
The Fly
Pliant Therapeutics price target lowered to $3 from $4 at Canaccord
5M ago
PLRX
How Shareholder Activism Could Disrupt Pliant Therapeutics’ Strategy, Costs, and Stock Performance
Premium
Company Announcements
How Shareholder Activism Could Disrupt Pliant Therapeutics’ Strategy, Costs, and Stock Performance
5M ago
PLRX
Pliant Therapeutics price target lowered to $3 from $4 at Piper Sandler
PremiumThe Fly
Pliant Therapeutics price target lowered to $3 from $4 at Piper Sandler
5M ago
PLRX
Pliant Therapeutics reports Q4 EPS (38c), consensus (38c)
PremiumThe Fly
Pliant Therapeutics reports Q4 EPS (38c), consensus (38c)
6M ago
PLRX
Pliant Therapeutics Extends Stockholder Rights Agreement Expiration
PremiumCompany Announcements
Pliant Therapeutics Extends Stockholder Rights Agreement Expiration
6M ago
8K
PLRX
PLRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PLRX Earnings this Week: How Will it Perform?
6M ago
PLRX
Pliant Therapeutics Appoints Minnie Kuo as COO
PremiumCompany AnnouncementsPliant Therapeutics Appoints Minnie Kuo as COO
8M ago
8K
PLRX
Pliant Therapeutics Announces Departure of Chief Medical Officer
Premium
Company Announcements
Pliant Therapeutics Announces Departure of Chief Medical Officer
9M ago
8K
PLRX
Pliant Therapeutics announces interim data from PLN-101095
Premium
The Fly
Pliant Therapeutics announces interim data from PLN-101095
9M ago
PLRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >